Hollister Incorporated, a global leader in healthcare products and services, proudly announces a groundbreaking policy shift benefiting thousands of Medicare beneficiaries living with spinal cord ...

Flow(TM) Voiding Prosthesis, following the Centers for Medicare & Medicaid Services (CMS) decision to establish national pricing for the CPT(R) codes related to physician procedures for the device.

Bladder cancer is often treated by removing visible tumors and using a type of immunotherapy called BCG, delivered through a ...

Imagine a targeted approach to bladder cancer that spares healthy cells while delivering chemotherapy directly to cancerous ones, offering hope for patients with advanced stages of the disease.

Documentation of any spinal cord injury diagnosis is sufficient to establish Medicare coverage for sterile catheter kits (A4297 and A4353) starting Jan. 1, according to a new local coverage determinat ...

The TAR‑200 slow‑release bladder implant cleared tumours in 82% of patients with high‑risk non‑muscle‑invasive bladder cancer ...

Asparagus aside—most of the reasons urine smells funny are harmless, but four urologists listed others you may not have been ...

Becton, Dickinson and Company BDX, popularly known as BD, expanded its PureWick portfolio with a new first-of-its-kind ...

IR uses the blood vessel network in the body as almost like a subway map. We can get on and off at different stops to access different parts of the body and treat disease. IR is the intersection of ...

NEW ORLEANS, LA—Sodium-glucose cotransporter 2 (SGLT2) inhibition does not seem to be a solution to the problem of arrhythmia ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, introduces the PureWick™ ...

TAR-200, a small drug-releasing implant, wiped out tumors in most patients with high-risk bladder cancer. Its slow, ...